Skip to main content
. Author manuscript; available in PMC: 2016 Jan 13.
Published in final edited form as: Nature. 2015 Oct 15;526(7573):343–350. doi: 10.1038/nature15817

Figure 2.

Figure 2

Approximately 7% percentage of medications (FDA approved) are affected by actionable inherited pharmacogenes (right), whereas approximately 18% of outpatient prescriptions in the US are affected by actionable germline pharmacogenomics (left),42 illustrating that several pharmacogenetically high-risk drugs are commonly prescribed.